Indira IVF removes IPO files after release Biopic Meri Kasam ‘on Fasam One

Mumbai: Indira IVF Trade Administrator Chain Worker Assistance Assistance

The company referred to evaluation of factors and trade considerations are reasons in relation to its decision.

However, the movement has come soon after Bollywood Bioland release in the founder Indira IVF, AJay Murdia.

The film named “Tumko Meri Kasam”, using an opam Kher and the company sent on his own body (Sebi) on February 13.

This period has made a predict of concerns about regulations with indirectly promoting rules.

According to Sebi’s latest updates, the IPO document has withdrawn officials on March 19th 2025.

While the report suggests that Sebi has created a concerned about biopice on the release of biopice releasing by IPO. Indira Ivf has denied participation in any regulations.

In the statement, the company spokesman was clearly withdrawal IPO is based on internal trade evaluation.

They also canceled the report that is recommended that Sebi told them to take this step.

A shopping spokesman and the consideration reported that “the company has been continuously considered.

Indira IVF is one of several companies that have discovered the road before filing a secret document for IPOs.

This option allows the company collecting personal details

It also provides 18 months to open the IPO after receiving the last comments of Sebi, compared to the limits of Sebi, compared to 12 months in the traditional process.

Supported by the Investment Company EQT, Indira IVF planned to add 4,500 crore through pure sales.

Of this, 2,900 CRore RS expect from Eqt, while Rs 600 crore will be canceled by the founder and promotional groups.